<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40590217</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-726X</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions</Title><ISOAbbreviation>Catheter Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>Transcatheter Versus Surgical Approach for the Treatment of Aortic Stenosis in Patients With Concomitant Coronary Artery Disease: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1661</StartPage><EndPage>1673</EndPage><MedlinePgn>1661-1673</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ccd.31697</ELocationID><Abstract><AbstractText>Aortic stenosis (AS) with concomitant coronary artery disease (CAD) requires an approach that addresses both valvular and coronary pathology. While surgical aortic valve replacement (SAVR) with coronary artery bypass graft (CABG) has long been the standard treatment, transcatheter aortic valve replacement (TAVI) with percutaneous coronary intervention (PCI) has become a less invasive alternative. This meta-analysis compares the clinical outcomes of TAVI&#x2009;+&#x2009;PCI versus SAVR&#x2009;+&#x2009;CABG in patients with AS and concomitant CAD. A systematic review and meta-analysis were conducted according to PRISMA guidelines. Fourteen studies, including two randomized controlled trials (RCTs) and 12 observational studies, with a total of 187,189 patients (31,298 in the TAVI&#x2009;+&#x2009;PCI group and 155,891 in the SAVR&#x2009;+&#x2009;CABG group) were included. Outcomes analyzed included 30-day mortality, stroke, major adverse cardiovascular and cerebrovascular events (MACCE), coronary reintervention, atrial fibrillation, major bleeding, vascular complications, acute kidney injury (AKI), perioperative myocardial infarction MI), permanent pacemaker implantation (PPI), length of hospital stay, and long-term survival. Patients undergoing TAVI&#x2009;+&#x2009;PCI were generally older (ranging from 76.3&#x2009;&#xb1;&#x2009;3.7 to 83.6&#x2009;&#xb1;&#x2009;3.7 years) and had higher rates of chronic kidney disease (CKD) compared to the SAVR&#x2009;+&#x2009;CABG group. Other comorbidities, such as diabetes and hypertension, were comparable between groups. The EuroSCORE varied widely (3&#x2009;&#xb1;&#x2009;2.2 to 36.1&#x2009;&#xb1;&#x2009;18.1), reflecting a mix of surgical risk profiles. TAVI&#x2009;+&#x2009;PCI was associated with a lower 30-day mortality rate (OR: 0.63, 95% CI: 0.37-1.07, p&#x2009;=&#x2009;0.09), though the result was not statistically significant. Stroke rates were comparable between the two groups (OR: 0.89, 95% CI: 0.70-1.14, p&#x2009;=&#x2009;0.36). There was no significant difference in MACCE (OR: 0.96, 95% CI: 0.50-1.84, p&#x2009;=&#x2009;0.91). However, coronary reintervention was significantly higher in the TAVI&#x2009;+&#x2009;PCI group (OR: 4.32, 95% CI: 2.58-7.23, p&#x2009;&lt;&#x2009;0.00001). TAVI&#x2009;+&#x2009;PCI was associated with an 82% lower risk of atrial fibrillation (OR: 0.18, 95% CI: 0.11-0.30, p&#x2009;&lt;&#x2009;0.00001) but a similar risk of major bleeding (OR: 0.71, 95% CI: 0.38-1.31, p&#x2009;=&#x2009;0.27). Vascular complications were significantly higher in the TAVI&#x2009;+&#x2009;PCI group (OR: 3.01, 95% CI: 1.52-5.93, p&#x2009;=&#x2009;0.002), while perioperative AKI was lower (OR: 0.46, 95% CI: 0.21-0.99, p&#x2009;=&#x2009;0.05). There was no significant difference in perioperative MI (OR: 0.78, 95% CI: 0.34-1.78, p&#x2009;=&#x2009;0.55). However, TAVI&#x2009;+&#x2009;PCI was associated with a higher likelihood of PPI (OR: 2.14, 95% CI: 1.88-2.43, p&#x2009;&lt;&#x2009;0.00001). The length of hospital stay was significantly shorter in the TAVI&#x2009;+&#x2009;PCI group (mean difference: -3.45 days, 95% CI: -5.79 to -1.12, p&#x2009;=&#x2009;0.004). Long-term survival favored TAVI&#x2009;+&#x2009;PCI (OR: 0.63, 95% CI: 0.49-0.80, p&#x2009;=&#x2009;0.0002). TAVI&#x2009;+&#x2009;PCI appears to be a viable alternative to SAVR&#x2009;+&#x2009;CABG, particularly in elderly or high-risk patients, with advantages such as lower long-term mortality, reduced atrial fibrillation, shorter hospital stays, and lower AKI rates. However, it carries a higher risk of coronary reintervention, vascular complications, and the need for PPI. These findings highlight the importance of individualized patient selection to balance risks and benefits.</AbstractText><CopyrightInformation>&#xa9; 2025 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bacha</LastName><ForeName>Zaryab</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Khyber Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Javed</LastName><ForeName>Javeria</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jinnah Sindh Medical University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khattak</LastName><ForeName>Fazia</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0004-0508-4765</Identifier><AffiliationInfo><Affiliation>Khyber Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qadri</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0006-8218-481X</Identifier><AffiliationInfo><Affiliation>Jinnah Sindh Medical University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoaib</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Khyber Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Izhar Muhammad</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Khyber Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Naveed Ahmed</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Khyber Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ali</LastName><ForeName>Muhammad Abdullah</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Khyber Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattumpuram</LastName><ForeName>Jishanth</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6359-3435</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tariq</LastName><ForeName>Muhammad Danyal</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Medicine, Mary Washington Healthcare, Fredericksburg, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fakhar</LastName><ForeName>Mashal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Mary Washington Healthcare, Fredericksburg, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afridi</LastName><ForeName>Abdullah</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Khyber Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakakhel</LastName><ForeName>Mian Zahid</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Rehman Medical College, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rath</LastName><ForeName>Shree</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0000-4273-0827</Identifier><AffiliationInfo><Affiliation>All India Institute of Medical Sciences, Bhubaneswar, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henna</LastName><ForeName>Fathimathul</ForeName><Initials>F</Initials><Identifier Source="ORCID">0009-0003-9875-9508</Identifier><AffiliationInfo><Affiliation>Dubai Medical College for Girls, Dubai, UAE.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>The authors received no specific funding for this work.</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Catheter Cardiovasc Interv</MedlineTA><NlmUniqueID>100884139</NlmUniqueID><ISSNLinking>1522-1946</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="Y">Coronary Artery Bypass</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="Y">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aortic stenosis</Keyword><Keyword MajorTopicYN="N">coronary artery bypass grafting</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">surgical aortic valve replacement</Keyword><Keyword MajorTopicYN="N">transcatheter aortic valve implantation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>5</Day><Hour>12</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>21</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40590217</ArticleId><ArticleId IdType="doi">10.1002/ccd.31697</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>B. A. Carabello and W. J. Paulus, &#x201c;Aortic Stenosis,&#x201d; Lancet 373, no. 9667 (March 2009): 956&#x2013;966.</Citation></Reference><Reference><Citation>B. A. Carabello, &#x201c;Introduction to Aortic Stenosis,&#x201d; Circulation Research 113, no. 2 (July 2013): 179&#x2013;185.</Citation></Reference><Reference><Citation>S. Yadgir, C. O. Johnson, V. Aboyans, et al., &#x201c;Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990&#x2010;2017,&#x201d; Circulation 141, no. 21 (2020): 1670&#x2013;1680, https://doi.org/10.1161/CIRCULATIONAHA.119.043391.</Citation></Reference><Reference><Citation>&#x201c;Aortic Stenosis,&#x201d; MSD Manual Professional Edition, https://www.msdmanuals.com/professional/cardiovascular-disorders/valvular-disorders/aortic-stenosis.</Citation></Reference><Reference><Citation>S. Y. Chen, X. Q. Kong, and J. J. Zhang, &#x201c;Pathological Mechanism and Treatment of Calcified Aortic Stenosis,&#x201d; Cardiology in Review 32, no. 4 (2024): 320&#x2013;327, https://doi.org/10.1097/CRD.0000000000000510.</Citation></Reference><Reference><Citation>D. Tomii, T. Pilgrim, M. A. Borger, et al., &#x201c;Aortic Stenosis and Coronary Artery Disease: Decision&#x2010;Making Between Surgical and Transcatheter Management,&#x201d; Circulation 150, no. 25 (2024): 2046&#x2013;2069, https://doi.org/10.1161/CIRCULATIONAHA.124.070502.</Citation></Reference><Reference><Citation>J. H. del Portillo, J. Farjat&#x2010;Pasos, A. Galhardo, et al., &#x201c;Aortic Stenosis With Coronary Artery Disease: SAVR or TAVR&#x2014;When and How?,&#x201d; Canadian Journal of Cardiology 40, no. 2 (2024): 218&#x2013;234, https://doi.org/10.1016/j.cjca.2023.09.023.</Citation></Reference><Reference><Citation>M. Ayyad, A. Jabri, B. B. Khalefa, et al., &#x201c;Efficacy and Safety of TAVR Versus SAVR in Patients With Small Aortic Annuli: A Systematic Review and Meta&#x2010;Analysis,&#x201d; International Journal of Cardiology 411 (2024): 132243, https://doi.org/10.1016/j.ijcard.2024.132243.</Citation></Reference><Reference><Citation>M. J. Page, J. E. McKenzie, P. M. Bossuyt, et al., &#x201c;The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews,&#x201d; British Medical Journal: BMJ [Internet] 372 (2021): n71, https://www.bmj.com/content/372/bmj.n71.</Citation></Reference><Reference><Citation>&#x201c;RoB 2: A Revised Cochrane Risk&#x2010;of&#x2010;Bias Tool for Randomized Trials,&#x201d; Cochrane Bias [Internet], cited July 13, 2024, https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials.</Citation></Reference><Reference><Citation>A. Stang, &#x201c;Critical Evaluation of the Newcastle&#x2010;Ottawa Scale for the Assessment of the Quality of Nonrandomized Studies in Meta&#x2010;Analyses,&#x201d; European Journal of Epidemiology 25, no. 9 (September 2010): 603&#x2013;605.</Citation></Reference><Reference><Citation>M. Egger, G. D. Smith, M. Schneider, and C. Minder, &#x201c;Bias in Meta&#x2010;Analysis Detected by a Simple, Graphical Test,&#x201d; BMJ 315, no. 7109 (1997): 629&#x2013;634, https://doi.org/10.1136/bmj.315.7109.629.</Citation></Reference><Reference><Citation>C. B. Begg and M. Mazumdar, &#x201c;Operating Characteristics of a Rank Correlation Test for Publication Bias,&#x201d; Biometrics 50, no. 4 (1994): 1088&#x2013;1101.</Citation></Reference><Reference><Citation>R. Suurmond, H. van Rhee, and T. Hak, &#x201c;Introduction, Comparison, and Validation of Meta&#x2010;Essentials: A Free and Simple Tool for Meta&#x2010;Analysis,&#x201d; Research Synthesis Methods 8, no. 4 (2017): 537&#x2013;553, https://doi.org/10.1002/jrsm.1260.</Citation></Reference><Reference><Citation>L. S&#xf8;ndergaard, J. J. Popma, M. J. Reardon, et al., &#x201c;Comparison of a Complete Percutaneous Versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results From the Randomized SURTAVI Trial,&#x201d; Circulation 140, no. 16 (2019): 1296&#x2013;1305, https://doi.org/10.1161/CIRCULATIONAHA.118.039564.</Citation></Reference><Reference><Citation>E. Kedhi, R. S. Hermanides, J. E. Dambrink, et al., &#x201c;Transcatheter Aortic Valve Implantation and Fractional Flow Reserve&#x2010;Guided Percutaneous Coronary Intervention Versus Conventional Surgical Aortic Valve Replacement and Coronary Bypass Grafting for Treatment of Patients With Aortic Valve Stenosis and Complex or Multivessel Coronary Disease (TCW): An International, Multicentre, Prospective, Open&#x2010;Label, Non&#x2010;Inferiority, Randomised Controlled Trial,&#x201d; Lancet (London, England) 404, no. 10471 (2025): 2593&#x2013;2602, https://doi.org/10.1016/S0140-6736(24)02100-7.</Citation></Reference><Reference><Citation>D. Wendt, P. Kahlert, T. Lenze, et al., &#x201c;Management of High&#x2010;Risk Patients With Aortic Stenosis and Coronary Artery Disease,&#x201d; Annals of Thoracic Surgery 95, no. 2 (2013): 599&#x2013;605, https://doi.org/10.1016/j.athoracsur.2012.07.075.</Citation></Reference><Reference><Citation>M. Barbanti, S. Buccheri, D. Capodanno, et al., &#x201c;Transcatheter or Surgical Treatment of Severe Aortic Stenosis and Coronary Artery Disease: A Comparative Analysis From the Italian OBSERVANT Study,&#x201d; International Journal of Cardiology 270 (2018): 102&#x2013;106, https://doi.org/10.1016/j.ijcard.2018.06.011.</Citation></Reference><Reference><Citation>H. Baumbach, E. R. Schairer, K. Wachter, et al., &#x201c;Transcatheter Aortic Valve Replacement: Management of Patients With Significant Coronary Artery Disease Undergoing Aortic Valve Interventions: Surgical Compared to Catheter&#x2010;Based Approaches in Hybrid Procedures,&#x201d; BMC Cardiovascular Disorders 19, no. 1 (May 2019): 108, https://doi.org/10.1186/s12872-019-1087-2.</Citation></Reference><Reference><Citation>A. Abugroun, M. Osman, S. Awadalla, and L. W. Klein, &#x201c;Outcomes of Transcatheter Aortic Valve Replacement With Percutaneous Coronary Intervention Versus Surgical Aortic Valve Replacement With Coronary Artery Bypass Grafting,&#x201d; American Journal of Cardiology 137 (2020): 83&#x2013;88, https://doi.org/10.1016/j.amjcard.2020.09.040.</Citation></Reference><Reference><Citation>A. Alperi, S. Mohammadi, F. Campelo&#x2010;Parada, et al., &#x201c;Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Complex Coronary Artery Disease,&#x201d; JACC: Cardiovascular Interventions 14, no. 22 (2021): 2490&#x2013;2499, https://doi.org/10.1016/j.jcin.2021.08.073.</Citation></Reference><Reference><Citation>S. H. Patlolla, H. V. Schaff, J. A. Dearani, J. M. Stulak, J. A. Crestanello, and K. L. Greason, &#x201c;Aortic Stenosis and Coronary Artery Disease: Cost of Transcatheter Vs Surgical Management,&#x201d; Annals of Thoracic Surgery 114, no. 3 (2022): 659&#x2013;666, https://doi.org/10.1016/j.athoracsur.2021.08.028.</Citation></Reference><Reference><Citation>A. L&#xe9;rault, A. Villecourt, T. Decottignies&#x2010;Dienne, et al., &#x201c;Catheter Versus Surgical Approach for the Management of Concomitant Aortic Stenosis and Coronary Artery Disease: An Inverse Probability Treatment Weighting Analysis,&#x201d; Archives of Cardiovascular Diseases 116, no. 3 (2023): 117&#x2013;125, https://doi.org/10.1016/j.acvd.2022.12.004.</Citation></Reference><Reference><Citation>A. Elderia, S. Gerfer, K. Eghbalzadeh, et al., &#x201c;Surgical Versus Interventional Treatment of Concomitant Aortic Valve Stenosis and Coronary Artery Disease,&#x201d; Thoracic and Cardiovascular Surgeon 71, no. 8 (2023): 620&#x2013;631, https://doi.org/10.1055/a-2003-2105.</Citation></Reference><Reference><Citation>A. McInerney, M. Garc&#xed;a M&#xe1;rquez, G. Tirado&#x2010;Conte, et al., &#x201c;In&#x2010;Hospital Outcomes Following Percutaneous Versus Surgical Intervention in the Treatment of Aortic Stenosis and Concomitant Coronary Artery Disease,&#x201d; Revista Espa&#xf1;ola De Cardiolog&#xed;a 76, no. 8 (2023): 600&#x2013;608, https://doi.org/10.1016/j.rec.2022.12.011.</Citation></Reference><Reference><Citation>W. Ullah, D. Sarvepalli, A. Kumar, et al., &#x201c;Trends and Outcomes of Combined Percutaneous (TAVI+PCI) and Surgical Approach (SAVR+CABG) for Patients With Aortic Valve and Coronary Artery Disease: A National Readmission Database (NRD) Analysis,&#x201d; Catheterization and Cardiovascular Interventions 102, no. 5 (2023): 946&#x2013;957, https://doi.org/10.1002/ccd.30832.</Citation></Reference><Reference><Citation>I. J. Amat&#x2010;Santos, M. Garc&#xed;a&#x2010;G&#xf3;mez, P. Avanzas, et al., &#x201c;Surgical Vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis,&#x201d; JACC: Cardiovascular Interventions 17, no. 21 (2024): 2472&#x2013;2485, https://doi.org/10.1016/j.jcin.2024.09.003.</Citation></Reference><Reference><Citation>V. Jagadeesan, J. H. Mehaffey, M. A. Kawsara, et al., &#x201c;Transcatheter Vs Surgical Aortic Valve Replacement in Medicare Beneficiaries With Aortic Stenosis and Coronary Artery Disease,&#x201d; Annals of Thoracic Surgery 119, no. 4 (2025): 843&#x2013;851, https://doi.org/10.1016/j.athoracsur.2024.12.016.</Citation></Reference><Reference><Citation>S. Garcia, R. J. Cubeddu, R. T. Hahn, et al., &#x201c;5&#x2010;Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease,&#x201d; JACC: Cardiovascular Interventions 14, no. 18 (2021): 1995&#x2013;2005, https://doi.org/10.1016/j.jcin.2021.07.004.</Citation></Reference><Reference><Citation>G. Talanas, A. Laconi, D. J. Kereiakes, et al., &#x201c;Long&#x2010;Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta&#x2010;Analysis of Randomized Trials,&#x201d; Journal of the Society for Cardiovascular Angiography &amp; Interventions 3, no. 7 (2024): 102143, https://doi.org/10.1016/j.jscai.2024.102143.</Citation></Reference><Reference><Citation>Y. Guo, W. Zhang, and H. Wu, &#x201c;Percutaneous Versus Surgical Approach to Aortic Valve Replacement With Coronary Revascularization: A Systematic Review and Meta&#x2010;Analysis,&#x201d; Perfusion 39, no. 6 (2024): 1152&#x2013;1160, https://doi.org/10.1177/02676591231178894.</Citation></Reference><Reference><Citation>Y. Sakurai, Y. Yokoyama, S. Fukuhara, H. Takagi, and T. Kuno, &#x201c;Complete Transcatheter Versus Surgical Approach to Aortic Stenosis With Coronary Artery Disease: A Systematic Review and Meta&#x2010;Analysis,&#x201d; Journal of Thoracic and Cardiovascular Surgery 167, no. 4 (2024): 1305&#x2013;1313.e9, https://doi.org/10.1016/j.jtcvs.2022.08.006.</Citation></Reference><Reference><Citation>G. P. Ussia, M. Barbanti, A. Colombo, et al., &#x201c;Impact of Coronary Artery Disease in Elderly Patients Undergoing Transcatheter Aortic Valve Implantation: Insight From the Italian CoreValve Registry,&#x201d; International Journal of Cardiology 167, no. 3 (2013): 943&#x2013;950, https://doi.org/10.1016/j.ijcard.2012.03.089.</Citation></Reference><Reference><Citation>C. Hennessy, J. Henry, G. Parameswaran, D. Brameier, R. Kharbanda, and S. Myerson, &#x201c;Percutaneous Coronary Intervention Vs. Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease: An Updated Systematic Review and Meta&#x2010;Analysis,&#x201d; Cureus 15, no. 11 (2023): e48297, https://doi.org/10.7759/cureus.48297.</Citation></Reference><Reference><Citation>D. S. Owens, M. J. Budoff, R. Katz, et al., &#x201c;Aortic Valve Calcium Independently Predicts Coronary and Cardiovascular Events in a Primary Prevention Population,&#x201d; JACC: Cardiovascular Imaging 5, no. 6 (2012): 619&#x2013;625, https://doi.org/10.1016/j.jcmg.2011.12.023.</Citation></Reference><Reference><Citation>E. Ko, D. Y. Kang, J. M. Ahn, et al., &#x201c;Association of Aortic Valvular Complex Calcification Burden With Procedural and Long&#x2010;Term Clinical Outcomes After Transcatheter Aortic Valve Replacement,&#x201d; European Heart Journal&#x2010;Cardiovascular Imaging 23, no. 11 (2022): 1502&#x2013;1510, https://doi.org/10.1093/ehjci/jeab180.</Citation></Reference><Reference><Citation>S. M. Hasan, F. Cikach, A. J. Toth, et al., &#x201c;Comparison of Outcomes and Discharge Location After Transcatheter vs. Surgical Aortic Valve Replacement With Prior Coronary Artery Bypass Grafting,&#x201d; Structural Heart 7, no. 1 (2022): 100120, https://doi.org/10.1016/j.shj.2022.100120.</Citation></Reference><Reference><Citation>L. J. Motloch, S. Reda, D. Rottlaender, et al., &#x201c;Postprocedural Atrial Fibrillation After Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement,&#x201d; Annals of Thoracic Surgery 93, no. 1 (2012): 124&#x2013;131, https://doi.org/10.1016/j.athoracsur.2011.08.078.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>